Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 1509-1513

  Yalamanchi, Shalini ^a   Flynn Jr , Harry W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Bevacizumab; Macular edema; Retinal vein occlusion

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; CASE REPORT; CENTRAL RETINAL THICKNESS; FOLLOW UP; HEMIRETINAL VEIN OCCLUSION; HUMAN; INTRAOCULAR PRESSURE; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA EDEMA; RETINA MACULA HEMORRHAGE; SUBRETINAL FLUID; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

EID: 81055125632     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/opth.s23698     Document Type: Article

References (16)

1. Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia and Australia. Ophthalmology. 2010;117:313-319.
2. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmology. 2001;131:61-77.
3. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2005;36:336-339.
4. Gregori NZ, Gaitan J, Rosenfeld PJ, et al. Long-term safety and efficacy of intravitreal bevacizumab (avastin) for the management of central retinal vein occlusion. Retina. 2008;28:1325-1337.
5. Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for macular edema following branch retinal vein occlusion: six month primary end point results of a Phase III study. Ophthalmology. 2010;117:1102-1112.
6. Brown DM, Campochiaro PA, Singh RP, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end points results of a phase III study. Ophthalmology. 2010;117:1124-1133.
7. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in the branch vein occlusion. Am J Ophthalmology. 1984;98:271-282.
8. The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology. 1995;102:1425-1433.
9. The SCORE Study Research Group. SCORE study report 5: a randomized trial to compare the efficacy and safety of intravitreal injection(s) of triamcinolone acetonide with standard care to treat vision loss associated with macular edema secondary to central retinal vein occlusion. Arch Ophthalmol. 2009;127:1101-1114.
10. The SCORE Study Research Group. SCORE study report 6: a randomized trial to compare the efficacy and safety of intravitreal injection(s) of triamcinolone acetonide with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion. Arch Ophthalmol. 2009;127:1115-1128.
11. Haller JA, Bandello F, Belfort R, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117:1134-1146.
12. Funk M, Kriechbaum K, Prager F, et al. Intraocular concentrations of growth factors and cytokines in retina vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci. 2009;50:1025-1032.
13. Figueroa MS, Contreras I, Noval S, et al. Results of bevacizumab as the primary treatment for retinal vein occlusion. Br J Ophthalmol. 2010;94:1052-1056.
14. Hoch AE, Ruppenstein M, Ach T, Dithmar S. OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2010;248:1567-1572.
15. Wolf-Schnurrbusch UE, Ghanem R, Rothenbuehler SP, et al. Predictors for short term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion. Invest Ophthalmol Vis Sci. 2011;52:3334-3337.
16. American Society of Retina Specialists Annual Preferences and Trends Survey, 2009. Available at: http://www.asrs.org. Accessed September 12, 2011.